Литература

Поставить закладку

Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012; 36:123–9.
Arayici S, Kadioglu S G, Oncel MY et al. The effect of histological chorioamnionitis on the short- term outcome of preterm infants ≤32 weeks: a single-center study J Matern Fetal Neonatal Med. 2014 Jul;27(11):1129-33
Chock VY., Punn R, Oza A et al. Predictors of Bronchopulmonary Dysplasia or Death in Premature Infants with a Patent Ductus Arteriosus Pediatr Res. 2014 April ; 75(4): 570–575.
Ohlsson A1, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2013 Apr 30;4:CD003481. doi: 10.1002/14651858.CD003481.pub5.).
Clyman R, Wickremasinghe A, Jhaveri N et al Ductus Arteriosus Feed or Fast with Indomethacin or Ibuprofen (DAFFII) Investigators. Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus. J Pediatr. 2013 Aug;163(2):406-11
Strychowsky JE, Rukholm G, Gupta MK, Reid D. Unilateral vocal fold paralysis after congenital cardiothoracic surgery: a meta-analysis. Pediatrics. 2014 Jun;133(6):e1708-23
Марасина А.В., Захарова М.Л., Мостовой А.В. с соавт. Парез левой голосовой складки после хирургического лечения открытого артериального протока у недоношенных детей. Уральский медицинский журнал. - 2014 №01(115). – С.69-75
Kabra N.S., Schmidt B., Roberts R.S., Doyle L.W., Papile L., et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007; 150(3): 229-34)
Vedovato S, Lo Iacono A, Morando C, Suppiej A, Orzan E, Trevisanuto D, Visentin S, Cavallin F, Chiarelli S, Zanardo V Sensorineural hearing loss in very low birth weight infants with histological chorioamnionitis J Matern Fetal Neonatal Med. 2014 Jul 11:1-5
Chorne N., Leonard С., Piecuch R., Clyman R.I. Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity. Pediatrics 2007; 119: 1165-71